Resources Library

This is the powerpoint presentation file of Leni von Bonsdorff from Day 3 Session 2 The Way Forward.

This is the powerpoint presentation file of Mariángela Vargas from Day 3 Session 1 Scale-up for domestic processing of plasma: technology options, equipment and oversight.

This is the powerpoint presentation file of Tomoko Hongo-Hirasaki from Day 3 Session 1 Scale-up for domestic processing of plasma: technology options, equipment and oversight.

This is the powerpoint presentation file of Josephine Cheng from Day 3 Session 1 Scale-up for domestic processing of plasma: technology options, equipment and oversight.

This is the powerpoint presentation file of Prity Bengani-Lutz from Day Session 1 Scale-up for domestic processing of plasma: technology options, equipment and oversight.

This is the powerpoint presentation file of Magdy El-Ekiaby from Day 2 Session 1 Options to improve the access to safe plasma protein products in LMIC.

This is the powerpoint presentation file of Salwa Hindawi from Day 2 Session 1 Options to improve the access to safe plasma protein products in LMIC.

This is the powerpoint presentation file of Pierre Tiberghien from Day 2 Session 1 Options to improve the access to safe plasma protein products in LMIC.

This is the powerpoint presentation file of Jeffrey McCullough from Day 2 Session 1 Options to improve the access to safe plasma protein products in LMIC.

This is the powerpoint presentation file of Giuliano Grazzini from Day 2 Session 1 Options to improve the access to safe plasma protein products in LMIC.

This is the powerpoint presentation file of Jan Bult from Day 1 Session 2 Options for fractionation of domestic plasma.

This is the powerpoint presentation file of Vee Armstrong from Day 1 Session 2 Options for fractionation of domestic plasma.

This is the powerpoint presentation file of Françoise Rossi from Day 1 Session 2 Options for fractionation of domestic plasma.

This is the powerpoint presentation file of Johan Prevot from Day 1 Session 1 Unmet Needs for Plasma-derived Medicinal Products in Low- and Middle-income Countries.

Recommendations in this document are made by the ISBT Working Party on Global Blood Safety in the context of improving quality and safety of recovered plasma to meet industry and regulatory requirements for fractionation to prepare essential plasma-derived medicinal products (PDMPs).